BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1160 related articles for article (PubMed ID: 28107554)

  • 1. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
    Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
    Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disregarding RBE variation in treatment plan comparison may lead to bias in favor of proton plans.
    Wedenberg M; Toma-Dasu I
    Med Phys; 2014 Sep; 41(9):091706. PubMed ID: 25186381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration and application of phenomenological RBE models for proton therapy.
    Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
    Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of relative biological effectiveness uncertainties into proton plan robustness evaluation.
    Ödén J; Eriksson K; Toma-Dasu I
    Acta Oncol; 2017 Jun; 56(6):769-778. PubMed ID: 28464736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
    Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of breathing motion and a variable relative biological effectiveness in proton therapy of left-sided breast cancer.
    Ödén J; Toma-Dasu I; Eriksson K; Flejmer AM; Dasu A
    Acta Oncol; 2017 Nov; 56(11):1428-1436. PubMed ID: 28826308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
    Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
    Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
    Paganetti H
    Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
    Henry T; Ödén J
    Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
    Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
    Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
    Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
    Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
    Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
    Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer.
    Marteinsdottir M; Paganetti H
    Phys Med Biol; 2019 Jun; 64(11):115027. PubMed ID: 31082810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of potentially variable RBE in liver proton therapy.
    Chen Y; Grassberger C; Li J; Hong TS; Paganetti H
    Phys Med Biol; 2018 Sep; 63(19):195001. PubMed ID: 30183674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liver.
    Carabe A; España S; Grassberger C; Paganetti H
    Phys Med Biol; 2013 Apr; 58(7):2103-17. PubMed ID: 23470339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.
    Zeng C; Giantsoudi D; Grassberger C; Goldberg S; Niemierko A; Paganetti H; Efstathiou JA; Trofimov A
    Med Phys; 2013 May; 40(5):051708. PubMed ID: 23635256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.